Navigation Links
Legislative Benefits and Unmet Needs to Drive the Market for Orphan Drugs, According to a New Report by Global Industry Analysts, Inc.
Date:9/4/2013

San Jose, California (PRWEB) September 04, 2013

Follow us on LinkedIn – Global demand for orphan drugs exhibits potential for healthy growth with rise in investments and interest of major pharmaceutical companies in orphan drug development. Factors such as rapidly aging population, increased incidence of orphan diseases among children, rise in diagnosis of rare cancers such as renal cell carcinoma, acute myeloid leukemia and thyroid cancer among others, are driving demand for novel therapies in the orphan drug market. Other factors driving market growth include legislative benefits such as extended market exclusivity period, tax credits, research assistance and partial funding of clinical trials. In addition, the growing number of orphan diseases and the lack of appropriate therapies resulting in significant unmet medical needs is a major factor generating interest in orphan drug development. Moreover, blockbuster sales of leading premium orphan drugs offers growth opportunities for companies involved in orphan drug development.

Despite the enormous potential offered, orphan drug development continues to face challenges in clinical trials such as the need for validated endpoints, patient recruitment and the lack of understanding of the progress of specific orphan conditions. Clinical trials involving therapies for rare diseases are impeded by the absence of adequate number of patients to study the efficacy of the drug. In addition, orphan drug development also suffers from lack of validated endpoints for a study and the unavailability of considerable clinical data for designing a study. In addition, the Eurozone crisis in Europe and the fiscal deficit in the United States and the resulting austerity measures adopted by governments to reduce spending in various areas including healthcare, also presents a challenging
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Adult Acne Treatment, Probiotic Action Shares Insight on Upcoming Conference on the Health Benefits of Probiotics
2. Probiotic Action Announces the Discovery of Four New Foods Claiming to Have Probiotic Benefits
3. PlantCellCulture.com Launched by DianaPlantSciences to Educate Industry and Consumers About Benefits of Plant Cell Culture Technology
4. Probiotic Action Announces New Use for Their Adult Acne Treatment and Explains its Beauty Benefits for Women
5. Recent Research Shows Benefits of Chiropractic Care for Infantile Colic
6. Dr. Carlos Szajnert, Announced today his Commitment to Further Educate his Patients on the Benefits of Cord Blood Stem Cells
7. New Research Confirms Bonicel's Multiple Anti-Aging Benefits
8. Notre Dame study explores the potential benefits and threats of nanotechnology research
9. Awareness of Omega-3 Benefits Soars
10. Mining cleanup benefits from Texas A&M expertise
11. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine” or the ... fraudulent press release disseminated this morning by PR Web, ... This press release states that Immunovaccine has entered into ... press release did not originate from Immunovaccine and there ... press release. Please note that all official statements ...
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company ... that it will be presenting at CALBIO 2015 at ... at 3pm PST. Patrick Lucy, chief business officer of ... state of the biosimilar industry landscape entitled The ... more information on CALBIO 2015 and The Evolving ...
(Date:2/27/2015)... Feb. 27, 2015   PureTech , a science ... commercializing disruptive products and technologies in the healthcare sector, ... former CEO and Member of the Board of Directors ... "It,s has been a pleasure to know Chris ... we will be working together more closely now," said ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4
... 13, 2008 at 5:00 am (Pacific) ... am (Eastern) / 8:00 pm (Beijing/Hong Kong), SHENYANG, ... ), a leading China-based biotechnology company focused on,researching, developing, ... release unaudited financial results,for the second quarter ended June ...
... July 29 - Federal, state, and,local forensic crime ... investigations during 2005, according to a report by ... cases included,requests for a variety of forensic services, ... examination., An estimated 359,000 cases were backlogged ...
... Discusses Impact of Bt Maize on His Farm and Family ... ... July 29, 2008 -- In a new online video released ... his family,s experience farming genetically modified Bt maize. Since ...
Cached Biology Technology:3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008 2Crime Labs Received an Estimated 2.7 Million Cases in 2005 2Crime Labs Received an Estimated 2.7 Million Cases in 2005 3South African Farmers Increase Plantings of Genetically Modified Crops 2South African Farmers Increase Plantings of Genetically Modified Crops 3
(Date:2/5/2015)... Jan. 27, 2015   Marvin Test ... deployed, innovative test solutions for military, aerospace, ... of its TS-323 GENASYS Test Platform ... (LMSSC). GENASYS is a high-performance PXI-based system ... applications that require performance functional testing. GENASYS ...
(Date:2/5/2015)... , Jan. 28, 2015 Research and Markets ... addition of the "Global Biometrics Market (2014-2020): ... and Countries " report to their offering. ... Asia-Pacific is anticipated to overtake ... owing to increasing government spending towards IT security, ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) ... Global Market Overview" report to their offering. , ... ensure that an individual is who she/he is claiming to ... of a person,s unique physical characteristics, such as fingerprint, hand ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... Only three percent (n=181) of patients in the ... treatment of their arthritis developed a first cancer within ... the type of arthritis. The nine year follow-up ... relative risk ((RR)=1.03 (95%confidence interval 0.82-1.30)) was not increased ...
... published in the current (May 27) edition of the journal ... that concluded that a bacterial bloom in the Gulf of ... The debate has implications for the Gulf of Mexico ... global warming, said marine scientist and lead author Samantha Joye, ...
... Thirty-eight million years ago, tropical jungles thrived in what are ... wandered temperate forests in what is now the frozen Antarctic. ... late Eocene, between the equator and Antarctica were half what ... the scientific community about what changes in our global climate ...
Cached Biology News:Arthritis patients taking newer treatments do not have an overall increased cancer risk 2Science paper argues against conclusion that bacteria consumed Deepwater Horizon methane 2Science paper argues against conclusion that bacteria consumed Deepwater Horizon methane 3Significant role of oceans in onset of ancient global cooling 2Significant role of oceans in onset of ancient global cooling 3
Human Dectin-1/CLEC7A Biotinylated Affinity Purified PAb...
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Profilin-1/2 (FL-140)...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
Biology Products: